{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-229293","form_type":"8-K","ticker":"LONA","cik":"0001620463","company_name":"LeonaBio, Inc.","filed_at":"2025-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.944215+00:00","generated_at":"2026-05-17T04:45:11.952898+00:00","sec_items":[],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Athira Pharma regains Nasdaq minimum bid price compliance; delisting risk removed","bullets":["Received Nasdaq notice on Oct 2, 2025 that closing bid price was $1.00+ for ten consecutive days.","Compliance with Nasdaq minimum bid requirement is regained and the matter is closed.","Previously notified of deficiency on Oct 16, 2024 when stock fell below $1.00 for 30 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-229293","json":"https://secwatch.observer/filing/0001193125-25-229293.json","markdown":"https://secwatch.observer/filing/0001193125-25-229293.md","text":"https://secwatch.observer/filing/0001193125-25-229293.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1620463/000119312525229293/0001193125-25-229293-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1620463/000119312525229293/atha-20251002.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:45:11.952898+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}